Description: Jinxin Fertility Group Limited, an investment holding company, provides assisted reproductive services (ARS) in China and the United States. The company primarily offers two treatment solutions, including artificial insemination that is performed with either husband's sperm or a donor sperm; and IVF technology, whereby fertilization is achieved through conventional in vitro fertilization and embryo transfer or IVF with intracytoplasmic sperm injection. It also provides related services, such as nutrition guidance, Chinese medicine treatment, and psychological counseling to support the ARS. In addition, the company offers management services; obstetrics, gynecology, urology, internal medicine, and pediatrics medical services; ambulatory surgery center facilities services; and ancillary medical services. Further, it offers pre-implantation genetic screening testing services; and engages in the investment management and management consultancy, postpartum and rehabilitation care, property investment, and real estate development and operation activities. Additionally, the company is involved in the sale of medicines, consumables, and equipment; and research and development of IVF related projects, including scientific research and related commercialization. Jinxin Fertility Group Limited was founded in 1951 and is headquartered in Chengdu, China.
Home Page: www.jxr-fertility.com
No. 301, North Jingsha Road
Chengdu,
China
Phone:
86 28 6769 5992
Officers
| Name | Title |
|---|---|
| Mr. Yong Zhong | Executive Chairman of the Board |
| Mr. Yang Dong | CEO & Executive Director |
| Ms. Rong Lyu | Co-CEO & Executive Director |
| Dr. John G. Wilcox FACOG, M.D. | Executive Director |
| Dr. Lihong Geng | Executive Director |
| Ms. Hanmei Huang | Chief Financial Officer |
| Ms. Hongmei Duan | Chief Operating Officer |
| Dr. Yuan Li | Chief Medical Officer |
| Ms. Yangyang Zhai | Joint Company Secretary |
| Ms. Sau Mei Ng ACIS, ACS, FCIS, FCS | Joint Company Secretary |
Exchange: F
Country: DE : Germany
Currency: Euro (€)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Health Care Equipment & Services |
| GIC Industry: | Health Care Providers & Services |
| GIC Sub-Industry: | Health Care Facilities |
| Forward PE: | 12.87 |
|---|---|
| Trailing PE: | 36.8 |
| Price-to-Book MRQ: | 0.763 |
| Price-to-Sales TTM: | 0.3484 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 3779 |